Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.

Gu Y, Jin S, Wang F, Hua Y, Yang L, Shu Y, Zhang Z, Guo R.

Biomed Pharmacother. 2014 May;68(4):471-5. doi: 10.1016/j.biopha.2014.03.010.

PMID:
24726064
2.

Survivin gene expression increases gastric cancer cell lymphatic metastasis by upregulating vascular endothelial growth factor-C expression levels.

Zhang J, Zhu Z, Sun Z, Sun X, Wang Z, Xu H.

Mol Med Rep. 2014 Feb;9(2):600-6. doi: 10.3892/mmr.2013.1858.

PMID:
24337012
3.

Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study.

Peng J, Fang Y, Tao Y, Li K, Su T, Nong Y, Xie F, Lai M.

PLoS One. 2014 Oct 6;9(10):e107362. doi: 10.1371/journal.pone.0107362.

4.

Up-regulation of PIK3CA promotes metastasis in gastric carcinoma.

Liu JF, Zhou XK, Chen JH, Yi G, Chen HG, Ba MC, Lin SQ, Qi YC.

World J Gastroenterol. 2010 Oct 21;16(39):4986-91.

5.

The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.

Tapia O, Riquelme I, Leal P, Sandoval A, Aedo S, Weber H, Letelier P, Bellolio E, Villaseca M, Garcia P, Roa JC.

Virchows Arch. 2014 Jul;465(1):25-33. doi: 10.1007/s00428-014-1588-4.

PMID:
24844205
6.

Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.

Kang MH, Oh SC, Lee HJ, Kang HN, Kim JL, Kim JS, Yoo YA.

Exp Cell Res. 2011 Jul 15;317(12):1746-62. doi: 10.1016/j.yexcr.2011.04.006.

PMID:
21570392
7.

Correlation between survivin mRNA expression and lymph node metastasis in gastric cancer.

Miyachi K, Sasaki K, Onodera S, Taguchi T, Nagamachi M, Kaneko H, Sunagawa M.

Gastric Cancer. 2003;6(4):217-24.

PMID:
14716515
8.

2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.

Lin HL, Yang MH, Wu CW, Chen PM, Yang YP, Chu YR, Kao CL, Ku HH, Lo JF, Liou JP, Chi CW, Chiou SH.

Int J Cancer. 2007 Dec 1;121(11):2547-55.

9.

Significance of Survivin and PTEN expression in full lymph node-examined gastric cancer.

Deng H, Wu RL, Zhou HY, Huang X, Chen Y, Liu LJ.

World J Gastroenterol. 2006 Feb 21;12(7):1013-7.

10.
11.

[Expression of vascular endothelial growth factor C and survivin in gastric carcinoma and their clinical implications].

Sun YS, Ye ZY, Zhao ZS, Shi D, Zou SC.

Zhonghua Wei Chang Wai Ke Za Zhi. 2006 May;9(3):264-7. Chinese.

PMID:
16721694
12.

Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.

Gao Q, Yang S, Kang MQ.

Mol Med Rep. 2012 Jun;5(6):1409-14. doi: 10.3892/mmr.2012.840.

PMID:
22446832
13.

L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.

Chen DL, Zeng ZL, Yang J, Ren C, Wang DS, Wu WJ, Xu RH.

J Hematol Oncol. 2013 Jun 27;6:43. doi: 10.1186/1756-8722-6-43.

14.

Akt and Cks1 are related with lymph node metastasis in gastric adenocarcinoma.

Lee SW, Kang SB, Lee DS, Lee JU.

Hepatogastroenterology. 2013 Jun;60(124):932-7. doi: 10.5754/hge121214.

PMID:
23321124
15.

Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.

Ye B, Jiang LL, Xu HT, Zhou DW, Li ZS.

Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):627-36.

PMID:
23058013
16.

Cytoplasmic localization of wild-type survivin is associated with constitutive activation of the PI3K/Akt signaling pathway and represents a favorable prognostic factor in patients with acute myeloid leukemia.

Serrano-López J, Serrano J, Figueroa V, Torres-Gomez A, Tabares S, Casaño J, Fernandez-Escalada N, Sánchez-Garcia J.

Haematologica. 2013 Dec;98(12):1877-85. doi: 10.3324/haematol.2013.083642.

17.

miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway.

Cao W, Yang W, Fan R, Li H, Jiang J, Geng M, Jin Y, Wu Y.

Tumour Biol. 2014 Feb;35(2):1287-95. doi: 10.1007/s13277-013-1171-7.

PMID:
24068565
18.

Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.

Yu W, Ma S, Wang L, Zuo B, Li M, Qiao Z, Pan X, Liu Y, Wang J.

Histol Histopathol. 2013 Dec;28(12):1629-38. doi: 10.14670/HH-28.1629.

PMID:
23836308
19.

The expression of TMPRSS4 and Erk1 correlates with metastasis and poor prognosis in Chinese patients with gastric cancer.

Luo ZY, Wang YY, Zhao ZS, Li B, Chen JF.

PLoS One. 2013 Jul 29;8(7):e70311. doi: 10.1371/journal.pone.0070311.

20.

Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer.

Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z.

World J Surg Oncol. 2012 Jun 8;10:103. doi: 10.1186/1477-7819-10-103.

Items per page

Supplemental Content

Support Center